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The constituent proteins of gap junctions, called connexins (Cxs), have a short half-life. Despite this, the physiological
stimuli that control the assembly of Cxs into gap junctions and their degradation have remained poorly understood. We
show here that in androgen-responsive human prostate cancer cells, androgens control the expression level of Cx32—and
hence the extent of gap junction formation—post-translationally. In the absence of androgens, a major fraction of Cx32 is
degraded presumably by endoplasmic reticulum–associated degradation, whereas in their presence, this fraction is
rescued from degradation. We also show that Cx32 and Cx43 degrade by a similar mechanism. Thus, androgens regulate
the formation and degradation of gap junctions by rerouting the pool of Cxs, which normally would have been degraded
from the early secretory compartment, to the cell surface, and enhancing assembly into gap junctions. Androgens had no
significant effect on the formation and degradation of adherens and tight junction–associated proteins. The findings that
in a cell culture model that mimics the progression of human prostate cancer, degradation of Cxs, as well as formation of
gap junctions, are androgen-dependent strongly implicate an important role of junctional communication in the prostate
morphogenesis and oncogenesis.
INTRODUCTION
Epithelial cells interact with their neighbors through junc-
tional complexes such as tight junctions, adherens junc-
tions, desmosomes, and gap junctions (Gumbiner, 2000;
Wheelock and Johnson, 2003; Saez et al., 2003; Getsios et al.,
2004). Apart from linking the cytoskeletal network of neigh-
boring cells, these complexes have been postulated to trans-
duce signals not only among cells within a population but
also from the interior of the cells to the extracellular milieu
reciprocally (Braga, 2002; Balda and Matter, 2004). Evidence
is mounting that this form of signaling is instrumental in
controlling the proliferation and differentiation of epithelial
cells and maintaining tissue homeostasis. Although each
junctional complex likely triggers a unique signaling cas-
cade, among all the junctional complexes studied so far, gap
junctions are highly specialized conglomerations of channels
that signal uncanonically, by permitting the direct exchange
of small molecules (#1500 Da) between the cytoplasmic
interiors of contiguous cells (Loewenstein, 1981, 1987; Saez et
al., 2003). The gap junction channels are formed of proteins
called connexins (Cxs), which are designated according to
their molecular mass (Saez et al., 2003). Currently ;20 dis-
tinct, but highly related, Cx genes have been cloned from
both human and mouse. The Cxs are transmembrane pro-
teins that traverse the membrane four times, share a similar
topology, and are expressed both redundantly as well as in
a tissue-specific manner (Wei et al., 2004; Sosinsky and Ni-
cholson, 2005). Evidence to date indicates that Cxs are trans-
ported to the cell surface as hexamers, also called connexons
or hemichannels, by sequential passage through endoplas-
mic reticulum (ER), Golgi, and trans-Golgi network
(VanSlyke and Musil, 2000; Segretain and Falk, 2004). All
Cxs, with the exception of Cx26, are phosphoproteins with a
relatively short half-life of 2–5 h, suggesting that the assem-
bly and disassembly of gap junctions are highly dynamic
processes (VanSlyke and Musil, 2000; Segretain and Falk,
2004; Laird, 2005; Solan and Lampe, 2005).
Gap junctional communication has been postulated to
fulfill the roles of intercellular buffering of cytoplasmic ions,
synchronization of cellular behavior, and regulation of cell
growth (Loewenstein, 1981; Saez et al., 2003). Although these
roles were well-supported by several studies, showing at-
tenuation of malignant phenotype upon forced expression of
Cx genes in Cx-deficient tumor cell lines (Mehta et al., 1991;
Zhu et al., 1991; Rose et al., 1993; Ruch, 1994; Trosko and
Ruch, 1998), convincing evidence supporting a key role for
gap junctions in regulating diverse physiological processes,
such as cell growth, differentiation, and apoptosis in vivo,
has recently emerged from the association of specific Cx
mutations with human genetic diseases and from tissue-
specific Cx knockouts in mice (Wei et al., 2004). For example,
Cx32 is abundantly expressed in the hepatocytes, and
knockout mice for this Cx exhibit a higher incidence of
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chemical- and radiation-induced liver tumors than their
wild-type counterparts, respectively (Temme et al., 1997;
King and Lampe, 2005a, 2005b). Also, Cx32 has been docu-
mented to act as a lung tumor suppressor, as assessed by
higher bronchioloalveolar tumor incidence (King and
Lampe, 2004; King et al., 2005a, 2005b). Distinct dominant
mutations in Cx26, a Cx abundantly expressed in the inner
ear and skin, have been shown to cause not only hearing loss
but also autosomal dominant disorders of epidermal kera-
tinization and differentiation (Kelsell et al., 2001). The above
studies lend credence to the long-standing notion that the
impaired and aberrant expression of Cxs—and consequently
passage of growth regulatory signals from cell-to-cell—can
have diverse pathological consequences, including patho-
genesis of cancer (Loewenstein, 1981; Trosko and Ruch,
1998).
Of all the known Cxs, Cx43 and Cx32 have been found to
be expressed in endocrine and exocrine glands (Meda, 1996;
Munari-Silem and Rousset, 1996). The prostate is an exocrine
gland that is comprised predominantly of two types of cells:
the epithelial cells, which line the ducts and acini, and the
mesenchymal cells, which form the stroma (Cunha et al.,
1987). Androgens, apart from regulating the development
and differentiation of male reproductive system before birth
and during puberty, play a major role not only in the devel-
opment of normal prostate but also in the survival and
maintenance of secretory (differentiation-related) function of
luminal epithelial cells of normal prostate because androgen
ablation, either by surgical or chemical means, induces ap-
optosis in these cells (Cunha et al., 1987, 1992). Paradoxically,
androgens are also required for the initial development of
prostate cancer because their removal triggers apoptosis in
malignant prostate epithelial cells, resulting in the regres-
sion of prostate tumors. Further progression of prostate
cancer is accompanied by the emergence of androgen-inde-
pendent malignant cells that lose their dependence on the
androgens for survival and proliferation (Feldman and
Feldman, 2001).
Our previous studies showed that the expression as well
as trafficking and assembly of Cx43 and Cx32, the 2 Cxs ex-
pressed by the well-differentiated epithelial cells of the normal
prostate, are impaired during prostate cancer progression both
in vitro and in vivo (Mehta et al., 1999; Govindarajan et al.,
2002). We have also shown that the basal epithelial cells in
normal prostate express Cx43, whereas luminal cells express
Cx32, and that the expression of the latter in the acinar
epithelial cells coincides with the acquisition of the differ-
entiated state (Habermann et al., 2001, 2002). Moreover, our
studies have documented that the reintroduction of Cx32
and Cx43 in an indolent, androgen-responsive human pros-
tate cancer cell line retards growth and induces differentia-
tion, whereas reintroduction of the same Cxs in an invasive,
androgen-independent cell line results in intracellular accu-
mulation with no concomitant effect on growth (Mehta et al.,
1999; Govindarajan et al., 2002). On the basis of the above
studies, we proposed that the differentiated state of epithe-
lial cells in normal prostate and in prostate tumors might
depend on the assembly of Cxs into gap junctions and that
the pathways that govern the trafficking and assembly of
Cxs into gap junctions are gradually impaired during the
progression of human prostate cancer from an androgen-
dependent state to an androgen-independent state (Mehta et
al., 1999; Govindarajan et al., 2002). Although it is well es-
tablished that the growth and differentiation of normal and
malignant prostate epithelial cells are influenced by the an-
drogens, limited knowledge exists regarding androgen-reg-
ulated genes that govern cell growth and differentiation
during prostate morphogenesis and oncogenesis (Feldman
and Feldman, 2001). Because Cx32 is expressed by the well-
differentiated luminal cells of the normal prostate and by the
epithelial cells of well-differentiated prostate tumors, we
investigated whether the formation and degradation of gap
junctions composed of Cx32 are regulated by the androgens
in an androgen-responsive human prostate cancer cell line
LNCaP.
We used LNCaP cells because they express androgen
receptor (AR), require androgens for both in vivo and in
vitro growth, express epithelial markers such as cytokeratin
8 and 18, and secrete prostate-specific antigen, which is
expressed by the normal prostate luminal epithelial cells (for
reviews see Webber et al., 1996; Karan et al., 2001; see also Lin
et al., 2001; Igawa et al., 2002). Moreover, these cells have
been widely used to study the effect of depletion of andro-
gens on cellular growth and differentiation in vivo and in
vitro (Cox et al., 2000; Deeble et al., 2001; Wright et al., 2003).
Furthermore, we used these cells because expression of Cx43
and Cx32 as well as of AR is heterogeneous in primary
cultures established from normal human prostate and pros-
tate tumors and is lost upon cultivation in vitro, as evi-
denced by several studies (reviewed in Webber et al., 1996),
including ours (Mehta et al., 1996). We show here that in this
cell culture model, androgens enhance the formation of gap
junctions composed of Cx32 post-translationally, by facili-
tating its trafficking from the ER to the cell surface. Con-
versely, Cx32 and gap junctions are degraded upon removal
of the androgens. We also present evidence that in the
absence of the androgens, Cx32 is degraded either from the
ER or immediately upon its exit before reaching Golgi, pre-
sumably, via endoplasmic reticulum–associated degrada-
tion (ERAD). This effect seems to be gap junction–specific,
because degradation of the adherens and tight junction pro-
teins is not significantly affected.
MATERIALS AND METHODS
Cell Culture
Androgen-responsive, early passage LNCaP cells (ATCC CRL 1740) and
DU-145 (ATCC CRL HTB-81) were grown in RPMI (GIBCO, Grand Island,
NY) containing 5% defined fetal bovine serum (Hyclone, Salt Lake City, UT)
in an atmosphere of 5% CO2/95% air, and stock cultures were maintained as
previously described (Mehta et al., 1999). During the course of these studies,
we used three separate lots of fetal bovine sera obtained from HyClone
Laboratories (Salt Lake City, UT) that varied considerably with respect to
steroid concentration and hence determined the basal level of Cx expression.
The retroviral packaging cell lines PA317 (ATCC CRL 9078), PTi-67 (Clontech
Laboratories, San Diego, CA) and Phoenix 293 (a gift from Dr. Michel Ouel-
lette, Eppley Institute) were grown in RPMI containing 5% defined fetal
bovine serum as described previously (Mehta et al., 1999). We also used
phenol red–free RPMI for experiments in which charcoal-stripped serum
(HyClone Laboratories) was used (see below).
Antibodies and Immunostaining
Hybridoma M12.13 (a gift from Dr. Dan Goodenough, Harvard University)
and a rabbit polyclonal antibody against Cx43 have been described earlier
(Mehta et al., 1991, 1992, 1999; Govindarajan et al., 2002). Rabbit anti-Golgi b
coatamer protein (PA1-061), rabbit anti-EEA-1 (PA1-063), rabbit anti-calreti-
culin (PA3-900), and mouse anti-TGN 38 (MA3-063) were from Affinity BioRe-
agents (Golden, CO). Mouse anti-occludin (clone OC-3F10) was from Zymed
Laboratories (South San Francisco, CA). Rabbit anti-a-catenin, rabbit anti-b-
catenin, rabbit anti-Cx32, mouse anti-b-actin (clone C-15) were from Sigma
(St. Louis, MO). Mouse anti-E-cadherin, mouse anti-a-catenin, mouse anti-b-
catenin antibodies were generously provided by Drs. Johnson and Wheelock
(Eppley Institute). A rabbit polyclonal anti-AR receptor antibody was from
Santa Cruz Biotechnology (sc-13062, San Diego, CA).
Cells were immunostained after fixing with 2% para-formaldehyde for 10
min as described previously (Mehta et al., 1991, 1992, 1999; Govindarajan et al.,
2002). Briefly, 1.5 3 105 cells, seeded in six-well clusters containing glass cover
slips, were allowed to grow to ;50% confluence. Cells were immunostained
at room temperature with various antibodies at appropriately calibrated
dilutions. Secondary antibodies (rabbit or mouse) conjugated with Alexa 488
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and Alexa 594 were used as appropriate. Images of immunostained cells were
acquired with Leica DMRIE microscope (Leica Microsystems, Wetzler, Ger-
many) equipped with Hamamatsu ORCA-ER CCD camera (Hamamatsu City,
Japan). For colocalization studies, serial z-sections (0.5 mm) were collected and
analyzed using image-processing software (Openlab 4.0; Improvision, Lex-
ington, MA).
Androgen Depletion and Other Treatments
Cells were seeded in six-well clusters containing glass coverslips (1.5–3 3
105), 6-cm (2 3 105), or 10-cm (3.5 3 105) dishes in 2, 4, and 10 ml complete
medium, respectively, and treated when ;50% confluent, by replenishing
with fresh medium containing various reagents at the desired concentration
added from stock solutions so that the final concentration of the solvent did
not exceed 0.3%. To grow cells under androgen-depleted conditions, normal
cell culture medium was replaced with androgen-depleted culture medium
consisting of phenol red–free RPMI and charcoal-stripped (steroid-depleted)
serum (5%, HyClone Laboratories). The controls received fresh medium
containing normal serum. Stock solutions of various reagents were prepared
as follows: MG132 from BIOMOL (Plymouth Meeting, PA; Lee and Goldberg,
1998; Goldberg and Rock, 2002) at 10 mM in ethanol; leupeptin (Calbiochem,
La Jolla, CA; Mehdi, 1991) at 100 mM in water; monensin from Calbiochem
(Tartakoff, 1983) at 10 mM in ethanol; mibolerone (MB; BIOMOL) at 1 mM in
ethanol. Lactacystin at 10 mM in water and acetyl-leu-leu-norleucinal (ALLN)
at 100 mM (BIOMOL) in DMSO. These solutions were stored at 220°C in
small aliquots.
Plasmids, Retroviral Vectors, and Other Recombinant
DNA Constructs
Retroviral vectors (pLXSN) containing rat Cx32 and Cx43 in sense orientation
were constructed as described (Mehta et al., 1991, 1999). A full-length AR
cDNA (a kind gift from Dr. K. Burnstein, University of Miami School of
Medicine) was subcloned into EcoRI site of retroviral vector, pMSCV-puro
(Clontech Laboratories). Carboxy terminus–deleted mutant rat Cx32, trun-
cated at position 220 (rCx32-T-220), was engineered by PCR-based cloning
technique using wild-type rCx32-cDNA cloned into pLXSN vector as a tem-
plate. The PCR amplification was performed using the forward primer: 59-
GCCGAATTCATGAACTGGACAGGTC-39, and reverse primer containing a
premature stop codon (TGA, Umber) at amino acid position 221: 59-CCG-
GAATTCTCAACGGCGGGCACAG-39. Both the forward and reverse primers
contained an EcoRI site as underlined. The PCR products were purified with
Qiaquick PCR purification kit (Qiagen, Chatsworth, CA), digested with EcoRI
and ligated into the EcoRI site of pLXSN. Plasmid pDsRed-Cx32-N1 was
generously provided by Dr. Falk (Lehigh University, Bethlehem, PA). Plas-
mid pEYFP-N1 was purchased from Clontech.
Retrovirus Production and Infection of Cells
Control and recombinant retroviruses harboring wild-type and mutant Cx
and AR cDNAs were produced in either amphotropic packaging cell line
PTi67 or in Phoenix 293 cells (Govindarajan et al., 2002). LNCaP and DU-145
cells were multiply infected with various recombinant retroviruses and se-
lected in G418 for 2–3 wk as described previously (Mehta et al., 1999). LNCaP
cells overexpressing AR were selected in puromycin (4 mg/ml). Glass cylin-
ders were used to isolate individual G418-resistant clones, which were ex-
panded, frozen, and maintained in G418 (200 mg/ml).
Blockage of Intracellular Protein Transport
The transport of proteins from ER to Golgi was blocked by incubating cells,
seeded in six-well clusters containing glass coverslips as described above, at
15°C in appropriate medium buffered with HEPES (pH 7) for 24 h in a CO2
free incubator (Bannykh et al., 1996). The transport of proteins between Golgi
compartments was blocked by treating cells for 8 h with 10 mM monensin
(Tartakoff, 1983).
RNA Isolation and RT-PCR Analysis
Total RNA was isolated from 50% confluent cultures using TRIzol reagent
(Invitrogen, Grand Island, NY) as described previously (Mehta et al., 1992).
Equal amount of total RNA (2–4 mg) was reverse-transcribed with M-MuLV
reverse transcriptase (New England Biolabs, Beverley, MA) using oligodT
primers in a reaction volume of 20 ml. The cDNA obtained was diluted to 100
ml, and equal volume (5 ml) from each reaction was used for PCR analysis. The
primers used for PCR analysis were as follows: forward primer 59-GCGC-
GAAGTGATCCAGAACC-39 and reverse primer 59-CTCCTTGGCGTTGT-
CAGAAATG-39 for hAR and forward primer 59-CAACGGCTCCGGCAT-
GTG-39 and reverse primer 59-GGCCAGCCAGGTCCAGACG-39 for human
b-actin cDNA as an internal control. Five-microliter aliquots of PCR reaction
were size-separated on a 1.5% agarose gel and stained with ethidium bro-
mide. After electrophoresis, the bands obtained were quantified using Quan-
tity One Software (Bio-Rad, Hercules, CA).
Real-Time PCR Analysis of RNA
Total cellular RNA was extracted under various conditions as described
above. cDNA was synthesized using 5 mg total RNA, oligo(dT)18 primer and
Superscript RT (Invitrogen). Quantitative real-time PCR was performed using
2 ml of a 1:50 dilution of first-strand cDNA in FastStart DNA Master SYBR
Green I (Roche Applied System, Indianapolis, IN) using primers specific to
Cx32 and GAPDH in iCycler (Bio-Rad, Hercules, CA). The following forward
and reverse primers were used: Cx32: 59-TCCTGCAGCTCATCCTAGT-39 and
59-CCTCAAGCCGTAGCATTTTC-39; GAPDH: 59- AGCCTCGTCCCGTAGA-
CAAAA-39 and 59-GATGACAAGCTTCCCATTCTCG-39. The efficiency of the
PCR reaction and the specificity of primers were determined using serial
dilutions of template cDNA and analyzing the melt curve data. Each cDNA
sample was used in duplicate, and a corresponding no cDNA sample was
included as a negative control. The amount of PCR product was monitored
after each cycle from the fluorescent intensity of double-strand specific SYBR
Green I. Cx32 mRNA levels were then normalized to the GAPDH mRNA
levels, and results were graphically represented as percentage difference in
mRNA level in normal and charcoal stripped conditions.
Western Blot Analysis
Preparation of cell lysates, detergent solubility of Cx32 and Cx43, and West-
ern blot analysis were performed as described (Musil and Goodenough, 1991;
Mehta et al., 1996, 1999; VanSlyke and Musil, 2000; Govindarajan et al., 2002)
except that cells were lysed in buffer SSK (10 mM Tris, 1 mM EGTA, 1 mM
PMSF, 10 mM NEM, 10 mM iodoacetamide, 10 mM NaF, 10 mM Na2VO4,
0.5% Triton X-100 [TX100], pH 7.4) supplemented with protease inhibitor
cocktail (Sigma, St. Louis, MO). For detergent solubility assay, the concentra-
tion of TX100 was raised to 1% before subjecting to centrifugation at 100,000 3
g for 60 min on a tabletop Beckman ultracentrifuge (Model TL-100, Fullerton,
Figure 1. Retroviral expression of Cx32 and gap junc-
tional communication in androgen-responsive LNCaP
cells. LNCaP cells were infected with the control and
Cx32-harboring recombinant retroviruses, and Cx32 ex-
pression level and junctional communication were deter-
mined by Western blot (A), immunocytochemical (B, left
panels) and functional (B, right panels) analyses. (A) Note
that only clones infected with Cx32-harboring retrovi-
ruses (lanes LN-32-1 and LN-32-2) express Cx32 (a 27-kDa
monomer and a 54-kDa dimer), whereas a control clone
infected with the control retrovirus (lane LN-NEO-1) and
parental, early passage cells (lane LN-WT) do not. (B)
Note that Cx32-expressing LNCaP cells form gap junc-
tions (green, bottom left panel, yellow arrows), whereas
no gap junctions are detected in control cells (top left
panel). The nuclei (red) were stained with DAPI. Note
extensive transfer of gap junctional permeable tracer, Lu-
cifer Yellow, in Cx32-expressing LNCaP clone (bottom
right panel) and lack of transfer in control cells (top right
panel). The microinjected cells are marked by the yellow
arrows. For Western blot analysis, 5 mg of total protein was loaded in each lane. After analyzing the expression of Cx32, the blot was stripped
and reprobed for b-actin to verify equal loading. The position of the molecular weight markers is indicated on the left.
S. Mitra et al.
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CA). The detergent-insoluble pellet was dissolved in buffer C (70 mM Tris/
HCl, pH 6.8, 8 M urea, 10 mM NEM, 10 mM iodoacetamide, 2.5% SDS, and 0.1
M DTT). Total, TX100-soluble and -insoluble fractions were mixed with 43
Laemmli buffer to a final concentration of 13 and incubated at room temper-
ature for 60 min before SDS-PAGE analysis.
Separation of Cytosolic and Membrane (Vesicular)
Fractions
Cx32-expressing LNCaP cells seeded on 10-cm tissue culture dishes were
washed twice with ice-cold 13 PBS (pH 7.4) and scraped in 1 ml of cold
rinsing buffer (13 PBS, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 10 mM NEM,
10 mM NaF, 10 mM Na2VO4, pH 7.4) supplemented with protease inhibitor
cocktail (Aldrich-Sigma, St. Louis, MO). Cells were then spun down and
resuspended in 1 ml of cold lysis buffer (10 mM Tris, 1 mM EGTA, 1 mM
PMSF, 10 mM NEM, 10 mM NaF, 10 mM Na2VO4, pH 7.4) supplemented with
protease inhibitor cocktail. The cells were disrupted by passing 10 times
through 22-, 25-, and 27-gauge needles sequentially. A 100-ml aliquot of cell
lysate was saved for protein estimation. Protein estimation was performed
using BCA method (Pierce, Rockford, IL). To the remaining cell lysate iodoac-
etamide (10 mM) was added, and the lysate was divided into two equal
halves (450 ml each). Ten percent SDS was added to one of the aliquots to a
final concentration of 1% and was kept aside as a total fraction. To the
remaining 450-ml aliquot, 2.5 M NaCl was added to a final concentration of
250 mM, followed by end-to-end rocking for 30 min at 4°C. The lysate was
then separated into cytosolic (supernatant) and membrane (pellet) fractions
by centrifugation at 100,000 3 g (35,000 rpm in analytical Beckman ultracen-
trifuge; Model l7-65 using a SW50.1 rotor) for 1 h at 4°C. The pellet was
dissolved in 450 ml of buffer C, and 2.5 M NaCl was added to a final
concentration of 250 mM. Equal volumes of total, cytosolic, and membrane
fractions were resolved by 12% SDS-PAGE and immunoblotted with anti-
Cx32 antibody. The blots were reprobed with anti-b-actin antibody as a
loading control. Ten micrograms of total protein was subjected to the SDS-
PAGE.
Determination of Connexin32 Half-life by Metabolic
Labeling and Pulse-Chase Analysis
Connexin32-expressing LNCaP were seeded in 60-mm dishes and grown to
50% confluence. The cells were then grown further for 18 h either in normal
serum or in androgen-depleted, charcoal-stripped serum containing 1) MB, 2)
lactacystin (100 mM), and 3) ALLN (100 mM). The cells were starved for
methionine and cysteine for 30 min in labeling medium (RPMI-1640 without
methionine and cysteine), after which the medium was then replaced with
fresh 2 ml labeling medium containing tran-35S-label (MP Biomedicals, Irvine,
CA) at 100 mCi/ml for 1 h. Cells were rinsed once and chased for various
times in RPMI-1640 containing 5% FBS or charcoal-stripped serum supple-
mented with 0.5 mM nonlabeled methionine and cysteine (chase medium).
Labeling and chase media contained MB, or lactacystin, and ALLN as appro-
priate. Cells were harvested at the indicated time points and lysed in SSK
buffer containing 0.6% SDS. Percent incorporation of the metabolic label was
determined by subjecting 10-ml aliquots (in triplicate) to trichloroacetic acid
(TCA) precipitation and counting in TRI-CARB 2900TR Liquid Scintillation An-
alyzer (Packard Bioscience, Meriden, CT) using Quantasmart Software One.
Equal TCA-insoluble counts per minute (CPMs) were used for immuno-
precipitating Cx32 as described below. Cx32 was immunoprecipitated as
described (VanSlyke and Musil, 2000) with minor modifications. Briefly, after
lysing cells, the SDS concentration was lowered to 0.1% by adding rinsing
buffer (13 PBS, pH 7.4, supplemented with 1 mM EGTA, 1 mM EDTA, 1 mM
PMSF, 10 mM NEM, 10 mM Na3VO4, 10 mM NaF, and protease inhibitor
cocktail). The lysates were precleared with protein A/G PLUS-Agarose beads
(40 ml; Santa Cruz Biotechnology) for 1 h at 4°C. Precleared lysates were then
used for immunoprecipitation of connexin32 using anti-rabbit Cx32 antibody
(1.5 mg) as described by Musil et al. (1990). Immunoprecipitates were eluted
with SDS sample buffer at room temperature for 30 min and analyzed on 12%
SDS-PAGE. The gels were processed for fluorography using Amplify (Am-
ersham Bioscience, Piscataway, NJ) following the manufacturer’s instructions,
dried, and imaged on Typhoon 9410 Variable Mode Imager (Amersham
Bioscience). The densitometric quantification was done using AlphaDigiDoc
1201 software.
Transient Transfection
LNCaP cells were seeded at a density of 3 3 105 per well on glass coverslips
in six-well clusters. After 24 h cells were transfected using FuGene 6 Trans-
fection Reagent (Roche Diagnostics, Alameda, CA) following manufacturer’s
instructions or as described (Govindarajan et al., 2002). A transfection effi-
ciency of 20–30% was observed with LNCaP cells.
Communication Assays
Gap junctional communication was assayed by microinjecting the following
fluorescent tracers: Lucifer Yellow (MW 443 Da; lithium salt); Alexa Fluor 488
(MW 570 Da; A-10436), and Alexa Fluor 594 (MW 760 Da; A-10438). All Alexa
dyes were obtained as hydrazide sodium salts from Molecular Probes (Carls-
bad, CA), and their stock solutions were prepared in water at 10 mM. Lucifer
yellow was microinjected as 5% aqueous stock solution. These fluorescent
tracers were microinjected into test cells by Eppendorf InjectMan and Fem-
toJet microinjection systems (models 5271 and 5242, Brinkmann Instrument,
Westbury, NY) mounted on Leica DMIRE2 microscope as described previ-
ously (Mehta et al., 1986, 1999; Govindarajan et al., 2002). The microinjected
cells were viewed and images captured with the aid of CCD camera (Retiga
2000R, FAST 1394) using QCapture (QImaging, Burnaby, British Columbia,
Canada). The captured images were stored as TIFF files and processed using
Corel photopaint (Ottawa, Ontario, Canada). Junctional transfer of fluorescent
tracer was quantitated by scoring the number of fluorescent cells (excluding
the injected one) from the captured TIFF images either at 1 min (Lucifer
Yellow) or at 15 min (Alexa 488 and Alexa 594) as described (Mehta et al.,
1986, 1991, 1999).
RESULTS
Retroviral-mediated Expression of Cx32 into LNCaP Cells
Our previous studies showed that LNCaP cells neither ex-
pressed Cx32 and Cx43 nor detectable levels of other known
Cxs (Mehta et al., 1996). Because these cells progress from
androgen-responsive to androgen-insensitive state upon se-
rial passage in vitro, with the early passage cells responsive
to androgens and the late passage cells becoming nonre-
sponsive (Igawa et al., 2002), we introduced Cx32 into early
passage LNCaP cells using a Cx32-harboring recombinant
retrovirus described previously (Mehta et al., 1999). Expres-
sion of Cx32 was confirmed in several randomly isolated
G418-resistant clones by Western blot and immunocyto-
chemical and functional analyses, and the representative
data from two such clones used in the present study are
shown in Figure 1. The data document that these clones
express abundant Cx32 (Figure 1A, LN-32-1 and LN-32-2),
and assemble it efficiently into functional gap junctions (Fig-
ure 1B, bottom panels), compared with the parental cells that
neither express Cx32 (Figure 1A, LN-WT and LN-Neo) nor
form functional gap junctions (Figure 1B, top panels). More-
over, these clones remain androgen-responsive for at least
100–200 population doublings after their isolation (data not
shown).
Androgens Enhance Cx32 Expression Level, Gap Junction
Assembly, and Junctional Communication
We first investigated the effect of androgens, both natural
(testosterone and its more active derivative di-hydrotestos-
terone, [DHT]) and synthetic androgen, mibolerone (MB), on
the expression of endogenous and retrovirally transcribed
Cx32 mRNA level by semiquantitative RT-PCR analysis and
found that they had no effect both in parental and Cx32-
expressing LNCaP cells (data not shown). Previous studies
had shown expression of Cx32 to be regulated post-transla-
tionally both in vivo and in vitro (Dermietzel et al., 1987;
Kren et al., 1993; Kojima et al., 1996), Therefore, we investi-
gated if androgens would regulate gap junction formation
and junctional communication by altering Cx32 expression
level post-transcriptionally and post-translationally. Figure
2 shows the effect of the natural and synthetic analogs of
androgens. Testosterone (Figure 2A), DHT and MB (Figure
2B), increased Cx32 expression level in dose-dependent
manner, and a significant increase in the expression could be
observed up to 72 h after treatment (Figure 2, A and B).
Based on three separate experiments, we chose synthetic
androgen, MB, for further studies because it increased Cx32
expression level significantly at a much lower, nontoxic
concentration (1–5 nM), compared with testosterone and
DHT, which produced a significant effect only at higher
concentrations (10–50 nM), which seemed cytotoxic (data
not shown). Concomitant with an increase in the expression
of Cx32, MB significantly increased its assembly into gap
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junctions as assessed immunocytochemically (Figure 2D, top
row, compare right and left panels) and by TX100 insolubil-
ity assay (Figure 2C), an assay that reliably measures the
assembly of Cxs into gap junctions, as documented by ear-
lier studies (Musil et al., 1990, 1991; VanSlyke and Musil,
2000), including ours (Govindarajan et al., 2002). Moreover,
as shown in Figure 2D, enhancement of gap junctional as-
sembly was accompanied by a parallel increase in junctional
communication, as assessed by the junctional transfer of
three gap junction–permeable fluorescent tracers, Lucifer
Yellow, Alexa 488 (MW 570), and Alexa 594 (MW 760). For
example, MB increased junctional transfer of Alexa 594 (MW
760) to several neighbors compared with control in which
transfer could be barely detected (Figure 2D, see also Table 1).
Because recent studies have shown that the protein com-
ponents of various junctional complexes interact to regulate
one another’s assembly and disassembly (Braga, 2002; Balda
and Matte, 2004), we examined whether MB increased the
expression of Cx32 and its assembly into gap junctions in-
directly, by altering the expression level of other cell junc-
tion–associated proteins. We found that MB had no signifi-
cant affect on the expression level of occludin and adherens
junction proteins E-cadherin and a- and b-catenins (Figure
2E). Taken together, these data suggest that the androgens
enhance Cx32 expression level post-translationally, with
concomitant increase in gap junction assembly, without sig-
nificantly altering the expression of adherens and tight junc-
tion–associated proteins.
Figure 2. Androgens increase Cx32 expression level and gap junction formation. Cx32-expressing LNCaP cells were treated with the
androgens as indicated. (A) Kinetics of enhancement of Cx32 level upon testosterone (10 nM) treatment. Note that significant enhancement
is observed up to 72 h. (B) Synthetic androgen, mibolerone (MB), is more potent than dihydro-testosterone (DHT) in increasing Cx32
expression level. Cells were treated with various concentrations of DHT and MB for 48 h. Note that MB is at least 4–5 times more potent than
DHT on an equimolar basis. (C and D) MB enhances Cx32 expression level and gap junction assembly. Formation of gap junctions was
analyzed by detergent insolubility of Cx32 by Western blot analysis (C) and by immunocytochemical analysis (D, top panels) 48 h after
treatment with MB (5 nM). Note an increase in size of gap junctions after treatment (compare control and treated, top panels). Note also that
increase in Cx32 expression level is accompanied by an increase in detergent-insoluble fraction. (D, bottom) junctional transfer of fluorescent
tracer, Alexa 594 (MW 760), was examined as described in Material and Methods. Note extensive junctional transfer to several first-order
neighbors upon MB treatment. (E) Androgens have no effect on adherens and tight junction proteins. Cx32-expressing LNCaP cells were
treated with various MB concentrations (1–10 nM) for 24 h. Expression of Cx32, adherens junction–associated proteins E-cadherin and a- and
b-catenins, and tight junction–associated protein, occludin, was analyzed by Western blot analysis of total cell lysate (5 mg). Detection of
E-cadherin and a-catenin was done simultaneously with monoclonal and polyclonal antibodies, respectively. Note that MB increased the
expression of only Cx32, but not of adherens and tight junction–associated proteins, at all the concentrations tested.
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Androgen Depletion Decreases Cx32 Expression Level, Gap
Junction Assembly, and Junctional Communication
Prompted by the data shown in Figure 2, we next investi-
gated the expression level of Cx32 and its subcellular fate in
LNCaP cells upon androgen depletion. Androgens were
removed from the serum by charcoal stripping. As assessed
immunocytochemically and by Western blot analysis of
TX100-soluble and -insoluble fractions, we found that an-
drogen depletion decreased Cx32 expression level and gap
junction assembly, which was prevented upon replenishing
androgens (Figure 3A, compare left, middle, and right pan-
els, and B). Temporal analysis revealed that a significant
decrease was observed as early as 4 h after androgen deple-
tion and was cell density dependent. In sparse cultures, a
conspicuous decrease was observed within 8–12 h after
androgen removal, whereas in confluent cultures at least
12–16 h were required to observe a significant effect (data
not shown). Based on the densitometric scanning analyses of
10 randomly chosen blots, androgen depletion consistently
decreased the expression level of Cx32 by 70–90% (see Fig-
ure 6C). To examine if decreased expression level of Cx32
and gap junction assembly reduced gap junctional commu-
nication, we measured junctional transfer of Lucifer Yellow
(MW 443 Da), Alexa 488 (MW 570 Da), and Alexa 594 (MW
760 Da). As shown in Figure 3C, androgen depletion de-
creased junctional transfer of Lucifer Yellow significantly,
which was prevented upon replenishing the charcoal-
stripped medium with MB. Androgen depletion also had
similar effect on the junctional transfer of both Alexa 488 and
Alexa 594 (see Table 1). As a control, depletion of androgens
had no effect on the junctional transfer of these tracers in
Cx32-lacking parental LNCaP cells (data not shown). These
data suggest that androgen depletion decreases Cx32 ex-
pression level and gap junction formation, with concomitant
decrease in function.
Androgen Receptor (AR) Regulates Cx32 Expression Level
and Gap Junction Formation
To investigate if androgens enhance Cx32 expression level
by acting through AR—and not through nongenotropic
mechanisms, we undertook three experimental approaches.
In the first approach, we treated Cx32-expressing LNCaP
cells with an anti-androgen, bicalutamide (Casodex, Astra-
Zeneca Pharmaceuticals, Newark, DE), which inhibits AR
signaling (Iversen, 2002). In the second approach, we over-
expressed AR in Cx32-expressing LNCaP cells by infecting
them with AR-containing recombinant retrovirus and iso-
lated polyclonal cultures. In the third approach, we intro-
duced Cx32 into another human prostate cancer cell line,
DU-145, which lacked AR. Bicalutamide (Casodex) de-
creased Cx32 expression level and gap junctions in charcoal-
stripped medium supplemented with MB (Figure 4A), as
well as in normal serum (data not shown). The size of gap
junctions increased in polyclonal cultures of Cx32-express-
ing LNCaP cells that overexpressed AR (Figure 4, B–D).
Androgen depletion had no significant effect on Cx32 ex-
pression level and gap junction formation in AR-lacking
DU-145 cells (Figure 4, E and F). These data suggest that
androgen-mediated activation of AR, and not androgen-
mediated nongenotropic effect, determined the expression
level of Cx32 and gap junction formation.
Androgen Depletion and Other Junctional Complexes
To test if androgen depletion affected components of other
cell junctions, we determined the expression level and de-
tergent solubility of adherens and tight junction–associated
proteins. Figure 5 shows that the expression level and de-
tergent solubility of adherens junction–associated proteins
(E-cadherin and a- and b-catenins) and the tight junction–
associated protein, occludin, did not decrease significantly
(Figure 5B). Moreover, these proteins remained localized at
cell-to-cell contact areas (Figure 5A). It is worth noticing that
although the total level of occludin did not decrease, andro-
gen depletion decreased its detergent-insoluble fraction,
with a concomitant increase in the soluble fraction (Figure
5B), leading to its intracellular accumulation (Figure 5A,
compare bottom right and left panels). Taken together, the
data suggest that among various junctional complexes stud-
ied, only the expression level of Cx32 and gap junction
formation seemed to decrease significantly upon removal of
androgens.
Androgen Depletion Triggers Degradation of Cx32 in the
Proteasome and Lysosome
We next investigated the mechanism by which androgen
depletion decreased the expression level of Cx32. Because
Cxs have been shown to be degraded by the proteasomal
and lysosomal pathways (Laing and Beyer, 2000; VanSlyke
et al., 2001; VanSlyke and Musil, 2002), we investigated if
Cx32 was degraded by these pathways upon androgen de-
pletion. For these analyses, we switched LNCaP cells to
charcoal-stripped medium in the presence of MG132, an
inhibitor of the proteasomal pathway (Goldberg and Rock,
2002), and leupeptin, an inhibitor of lysosomal pathway
Table 1. Effect of androgens and androgen depletion on junctional transfer in Cx32-expressing LNCaP cells
Junctional transfera
Junctional tracer Expt NS NS1MBb STRIPc STRIP1MBc
LY 1 12.7 6 3.4 (12) 24.6 6 5.7 (16) ND ND
2 11.2 6 3.9 (14) 26.6 6 4.5 (14) ND ND
Alexa 488 1 13.9 6 6.3 (15) 18.1 6 4.5 (15) 5.1 6 4.3 (9) 28.7 6 13 (29)
2 9.2 6 4.4 (11) 15.2 6 2.5 (12) 3.1 6 3.8 (16) 29.8 6 09 (29)
Alexa 594 1 5.7 6 2.0 (15) 11.1 6 2.0 (15) 0.2 6 0.7 (9) 10 6 4.8 (30)
2 2.1 6 0.7 (10) 8.3 6 3.9 (12) 0.0 6 00 (16) 8 6 4.6 (17)
ND, not determined; NS, normal serum. Values are mean 6 SD, with the total number of injection trials in parentheses.
a The number of fluorescent cell neighbors 1 min (LY) and 15 min (Alexa 488 and Alexa 594) after injection of the tracer into test cell.
b Cells were treated for 24 h with mibolerone (MB, 5 nM).
c Cells were grown in charcoal-stripped (STRIP) serum for 24 h without or with MB (STRIP1MB).
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(Mehdi, 1991). Treatment with both inhibitors prevented the
decline in Cx32 expression level upon androgen depletion as
assessed by immunocytochemical (Figure 6A) and Western
blot (Figure 6B) analyses. Moreover, a major proportion of
Cx32 accumulated intracellularly and no immunocytochem-
ically detectable gap junctions were observed (Figure 6A).
Furthermore, combined treatment with MG132 and leupep-
tin resulted in higher intracellular accumulation than treat-
ment with either inhibitor alone (Figure 6, A and B). These
data suggest that upon androgen depletion Cx32 was de-
graded both by the proteasomal and lysosomal pathways
and that the effect of these inhibitors was additive, raising
the possibility that the inhibitors acted on different Cx pools.
We also determined the level of Cx32 mRNA (Figure 6D)
Figure 3. Androgen depletion decreases Cx32 expression level, gap junctions, and junctional communication. Cx32-expressing LNCaP cells were
switched to charcoal-stripped (STRIP) medium. Formation of gap junctions was analyzed by immunocytochemical analysis (A) after 48 h, by
Western blot analysis of total, detergent-soluble and -insoluble fractions (B), and by junctional transfer of Lucifer Yellow (C). Note that Cx32
and gap junctions are degraded in charcoal-stripped serum (STRIP), and degradation is prevented upon replenishment of 5 nM MB
(STRIP1MB). Note also the larger size of gap junctions in cells treated with MB. Note also lack of junctional transfer of Lucifer Yellow in cells
grown under charcoal-stripped serum.
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and protein (Figure 6C) in normal medium and in charcoal-
stripped medium to test if androgen depletion altered its
transcription from retroviral long-terminal repeats (LTRs)
by quantitative real-time PCR and Western blot analyses.
Figure 6, C and D, shows that whereas the retroviral Cx32
mRNA level was not significantly affected by the androgens,
protein levels decreased by ;70%. Taken together these data
suggest that androgen depletion alters the expression level
of Cx32 by regulating its degradation in the proteasome and
lysosome post-translationally—and not by altering Cx32
mRNA level transcribed from the viral promoter.
Androgen Depletion Degrades Cx32 Before its Assembly
into Gap Junctions
The half-life of Cxs has been estimated to be 2–5 h in vivo
and in vitro (Musil and Goodenough, 1991; VanSlyke and
Musil, 2000; VanSlyke et al., 2001). Previous studies showed
that up to 40–50% of newly synthesized pool of Cxs was
degraded by ERAD in the proteasome (VanSlyke et al., 2001;
VanSlyke and Musil, 2002), whereas the cell surface and gap
junction–associated pools were degraded in the lysosome
(VanSlyke and Musil, 2005). Therefore, we investigated
Figure 4. Androgen receptor mediates increase in Cx32 expression. (A) Cx32-expressing LNCaP cells were grown in charcoal-stripped
serum containing 5 nM MB in the presence (top right panel) and absence (top left panel) of 10 mM Casodex (bicalutamide) for 24 h. Note
absence of gap junctions in cells grown in Casodex. (B) Androgen-receptor (AR) was overexpressed in Cx32-expressing LNCaP cells using
AR-harboring retrovirus as described in Materials and Methods. Formation of gap junctions (yellow) was studied immunocytochemically. Note
increase in size of gap junctions in cells expressing higher level of AR (labeled LN-32-AR, right panel) compared with those expressing basal
level (labeled LN-32, left panel). (C and D) AR mRNA (C) and protein (D) were determined semiquantitatively by RT-PCR and Western blot
analysis in Cx32-expressing LNCaP cells (labeled LN-32) and in polyclonal cultures after infection with AR containing retrovirus (labeled
LN-32-AR). Note the higher level of AR mRNA (C) and protein (D) in infected polyclonal cultures. (E and F) Cx32-expressing, AR-negative,
DU-145 cells were grown in charcoal-stripped serum (STRIP) in the presence and absence of MB for 24 h. Cx32 expression level and gap
junctions were analyzed immunocytochemically (E) and by Western blot analysis (F). Cells grown in normal serum were used as controls.
Note lack of Cx32 and gap junction degradation upon androgen depletion.
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whether androgen depletion caused degradation of only
intracellular pool of Cxs or the cell surface and gap junction–
associated pool. For these investigations, Cx32-expressing
LNCaP cells were switched to charcoal-stripped serum for
24 h, which depleted most of pre-existing intracellular and
the cell surface–associated pools (both junctional and non-
junctional) of Cx32 (Figure 7). Cells were then grown for an
additional 24 h as follows: 1) in charcoal-stripped serum
alone, 2) in charcoal-stripped serum containing MG132, leu-
peptin or MB alone, and 3) in charcoal-stripped serum sup-
plemented with both MB and MG132 or leupeptin. Degra-
dation, subcellular localization and detergent solubility of
Cx32 were then analyzed by immunocytochemical and
Western blot analyses. Figure 7 shows the representative
data from one of five such experiments. No significant in-
tracellular or junctional immunostaining was noticed when
cells were grown for an additional 24 h in charcoal-stripped
serum in the absence (Figure 7Aa) or presence of leupeptin
(Figure 7Ac) because Cx32 did not form gap junction or a
cell surface–associated pool whose degradation was leupep-
tin-sensitive. However, substantial intracellular accumula-
tion was observed when cells were grown in charcoal-
stripped serum containing MG132 and only then (Figure
7Ab). Moreover, gap junctions were observed only in cells
treated with either MB alone or with MB and MG132 or
leupeptin (Figure 7A, d–f). Furthermore, the combined effect
of MB and MG132 was not additive (Figure 7A, compare gap
junctional staining in panel d with panel e), indicating that
MB rerouted MG132-sensitive pool of Cx32 to the cell sur-
face for gap junction assembly. Some intracellular accumu-
lation of Cx32 was observed in cells grown in charcoal-
stripped serum containing MB and leupeptin (Figure 7Af).
This most likely represents a pool of Cx32 that was assem-
bled into gap junctions in the presence of MB to form leu-
peptin-sensitive pool targeted to lysosomal degradation
(VanSlyke and Musil, 2005). Consistent with the immuno-
cytochemical data, a corresponding increase in the Cx32
detergent-insoluble fraction was observed in cells grown in
charcoal-stripped serum containing MG132 and MB com-
pared with MG132 alone (Figure 7B). These data clearly
indicate that MB facilitates gap junction assembly of MG132-
sensitive pool.
Because intracellularly accumulated Cx32 appeared as
discrete spots of variable sizes that seemed to be distributed
throughout the cytoplasm (Figure 7Ab), we examined its
subcellular fate. Colocalization experiments revealed that
Cx32, which was rescued upon proteasomal inhibition after
androgen depletion, did not reside in the ER, lysosome,
Golgi, and trans-Golgi network, as assessed by confocal
microscopy using specific markers for these compartments
(data not shown). Because Cx43 and Cx32 have been recov-
ered in an intact soluble form from the cytosol upon inhibi-
tion of proteasomal function (VanSlyke and Musil, 2002,
2005), we investigated if intracellularly accumulated Cx32
resided in the cytosol or in some vesicular compartment. For
these investigations, we separated membrane and cytosolic
fractions from cells, which had been grown in normal and
charcoal-stripped serum in the presence and absence of MB
or MG132, by centrifuging the extracts at 100,000 3 g and
determined the Cx32 level in the pellet and supernatant by
Western blot analysis (see Materials and Methods). A repre-
sentative Western blot is shown in Figure 7C. As assessed by
the densitometric scanning analysis of three blots, we found
that between 80 and 90% of intracellularly accumulated
Cx32 remained in the pellet (membrane/vesicular fraction)
and was not present in the supernatant that represented the
cytosolic fraction. Taken together, these results show that in
the absence of androgens, a major portion of Cx32 is de-
graded before its assembly into gap junctions, and degrada-
tion involves an as yet unidentified intermediate compart-
ment.
Androgen Depletion Triggers Cx32 Degradation En Route
to Golgi
In the next series of experiments, we investigated if Cx32
was degraded directly from the ER or en route to the cell
surface from the Golgi or trans-Golgi network upon inhibi-
tion of proteasomal function. We used brefeldin, which in-
Figure 5. Androgen depletion does not affect degrada-
tion of adherens and tight junction–associated proteins.
Cx32-expressing LNCaP cells, grown either in six-well
clusters or 10-cm dishes, were switched to charcoal-
stripped (STRIP) medium. After 48 h, degradation of
Cx32 and formation of gap junctions and that of tight
and adherens junction–associated proteins occludin and
E-cadherin and a- and b-catenins were assessed immu-
nocytochemically (A) and biochemically by TX100 in-
solubility assay (B) as described in Materials and Meth-
ods. Note that the expression level of only Cx32
decreased in charcoal-stripped (STRIP) serum. Note
also that the expression level of E-cadherin and a- and
b-catenins as well as of occludin did not decrease in the
presence and absence of androgens (B) and these pro-
teins remained localized at cell–cell contact areas (A). T,
total; S, TX100-soluble fraction; I, TX100-insoluble frac-
tion.
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hibits ER-to-Golgi transport (Klausner et al., 1992; Chardin
and McCormick, 1999), and monensin, which inhibits trans-
port from the cis-Golgi to the medial Golgi compartment
(Tartakoff , 1983). The data from several pilot experiments in
LNCaP cells showed that brefeldin did not block the trans-
port of Cx32 from ER to Golgi effectively. However, we
found that ER-to-Golgi transport could be effectively
blocked by incubating cells at 15°C (Bannykh et al., 1996;
Hauri et al., 2000), whereas transport from cis-to medial-
Golgi could be blocked with monensin.
To determine the site of degradation of Cx32 upon androgen
depletion, we first switched LNCaP cells to charcoal-stripped
serum for 24 h to deplete its pre-existing intracellular and cell
surface–associated (junctional and nonjunctional) pools. The
cells were then grown for an additional 24 h in charcoal-
stripped serum in the presence and absence of androgens
and treated with monensin during the last 8 h. Cells that
were continuously grown in normal serum or charcoal-
stripped medium supplemented with MB without monensin
were used as controls. The degradation and the subcellular
localization of Cx32 were analyzed by immunocytochemical
analysis. Figure 8A shows the representative data from one
of three such independent experiments. We found that in
stark contrast to E-cadherin, Cx32 was degraded and did not
accumulate intracellularly under androgen-depleted condi-
tions (Figure 8A, c and d) even when intra-Golgi transport
was blocked by monensin for 8 h (Figure 8Ad). On the other
hand, in control cells (Figure 8A, a and b) or androgen-
treated cells (Figure 8A, e and f), substantial intracellular
accumulation of both Cx32 and E-cadherin was observed
upon monensin treatment (Figure 8A, b and f). These data
suggest that Cx32 is degraded before the site of monensin
action, i.e., in the early secretory pathway comprised of ER
and cis-Golgi, and is rescued from degradation by the an-
drogens.
To determine further the site of degradation, cells were
grown in charcoal-stripped serum for 24 h to deplete the
pre-existing pool of Cx32 as described above. These cells
Figure 6. Cx32 degrades via the proteasomal and lysosomal pathway upon androgen depletion. Cx32-expressing LNCaP cells, seeded in
six-well clusters containing glass coverslips for immunocytochemical analysis (A), in 10-cm dishes for Western blot analysis (B and C), and
in 6-cm dishes for RT-PCR analysis (D), were allowed to grow to 50% confluence. Cells were then further grown for 24 h in normal serum
(CONTROL), in charcoal-stripped serum alone (STRIP), or in charcoal-stripped serum supplemented with MG132 (20 mM; STRIP1MG132),
leupeptin (50 mM; STRIP1LEUP), and MG132 and leupeptin (STRIP1MG1321LEUP). Degradation and subcellular localization of Cx32 were
analyzed by immunocytochemical (A) and Western blot (B) analyses as described in Materials and Methods. (A) Note that Cx32 and gap
junctions are degraded in charcoal-stripped serum, and there is no intracellular accumulation, and degradation is prevented by MG132 and
leupeptin, with combined treatment resulting in higher intracellular level. (B) Western blot analysis of total cell lysates. Note that Cx32 is
degraded in charcoal-stripped serum (STRIP), and degradation is prevented by MG132 (STRIP1MG132) and leupeptin (STRIP1LEUP), and
combined treatment is additive (STRIP1MG1321LEUP). (C and D) Cx32 mRNA and protein levels were measured by quantitative real-time
PCR analysis (D) and by quantifying Western blots (C) as described in Material and Methods. Total RNA was extracted from Cx32-expressing
cells grown in normal serum (NS) or charcoal-stripped serum for 24 h (STRIP). Note that the Cx32 mRNA levels did not change significantly,
but protein levels decreased by ;70%. NS, normal serum; LEUP, leupeptin; STRIP, charcoal-stripped serum.
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were then grown for an additional 24 h at 37 or 15°C with or
without MG132 in medium containing normal or charcoal-
stripped serum. Subcellular localization of Cx32 was deter-
mined immunocytochemically. Figure 8B shows the repre-
sentative data from one of five such experiments. The data
show that at 15°C, Cx32 accumulated intracellularly in cells
grown in normal serum (Figure 8Bc) but was degraded in
cells grown in charcoal-stripped serum for 24 h (Figure 8Bd).
The degradation was substantially prevented when cells
were grown in the presence of MG132 at 15°C in charcoal-
stripped serum (Figure 8Bf). These data suggest that upon
androgen depletion, a major fraction of Cx32 is degraded
either from the ER itself or from the ER-to-Golgi intermedi-
ate compartment.
Androgen-regulated ERAD of Cx32
To substantiate the above data, we undertook two kinds of
experimental approaches. In the first approach, we trans-
fected Cx32-expressing LNCaP cells transiently with DsRed-
Cx32, which remains trapped in the ER (Lauf et al., 2001),
together with pEYFP-N1. Twelve-hours after transfection,
medium was replaced and cells were switched to normal
and charcoal-stripped serum with or without MB or MG132.
Degradation of ER-trapped DsRed-Cx32 was assessed 24 h
Figure 7. Androgen depletion degrades Cx32 before its assembly into gap junctions. (A and B) Cx32-expressing LNCaP cells were seeded for
immunocytochemical (A) and Western blot (B) analyses as in Figure 6. Cells were switched to charcoal-stripped conditions for 24 h to deplete the
pre-existing pool of Cx32. Cells were then grown for an additional 24 h either in charcoal-stripped serum alone (STRIP) or in charcoal-stripped
serum supplemented with MG132 (STRIP1MG132), leupeptin (STRIP1LEUP), MB alone (STRIP1MB), or with MG132 (STRIP1MG1321MB) or
leupeptin (STRIP1LEUP1MB). Degradation, subcellular localization and detergent solubility of Cx32 was studied by immunocytochemical and
Western blot analyses as described in Materials and Methods. (A) Note that no significant intracellular Cx32 (red) is observed in cells grown in
charcoal-stripped serum (a) or charcoal-stripped serum with leupeptin (c). Note that extensive intracellular accumulation (red puncta) was
observed only in cells grown in charcoal-stripped serum containing MG132 (b). Note that gap junctional immunostaining was observed in cells
grown in MB in the presence (e) or absence of MG132 (d) and leupeptin (f). Note also that gap junctional staining was observed upon treatment
of charcoal-stripped cells with MB (d) or with MB and MG132 (e), and there was no intracellular accumulation. (B) Note also that significant increase
in the detergent-insoluble fraction of Cx32 was observed in cells grown in charcoal-stripped serum in the presence of MB and MG132
(STRIP1MB1MG132) compared with MG132 alone (STRIP1MG132). (C) Intracellularly accumulated Cx32 resides in the membrane/vesicular
fraction upon proteasomal inhibition. Cx32-expressing LNCaP cells were switched to charcoal-stripped serum for 24 h. Cells were further grown
for 24 h in charcoal-stripped serum alone (STRIP) and charcoal-stripped serum supplemented with MB (STRIP1MB) or MG132 (STRIP1MG132).
Cells maintained in normal serum were used as controls. Total (T), membrane (P), and cytosolic (S) fractions were subjected to Western blot analysis
as described in Materials and Methods.
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later by immunocytochemical analysis (Figure 9 legend). As
shown in Figure 9A, we found that ER-trapped DsRed-Cx32
was degraded effectively upon androgen depletion (Figure
9A, compare column 1 with column 2), and the degradation
was prevented by MB (Figure 9A, column 3) or MG132
(Figure 9 A, column 4). In the second approach, we analyzed
the metabolic turnover of Cx32 under normal condition as
well as androgen-depleted condition in the presence and
absence of androgens and proteasomal inhibitors lactacystin
and ALLN. Cells were metabolically labeled and chased for
1–4 h in the presence of indicated treatments (see Materials
and Methods, Figure 9 legend). As shown in Figure 9, B and
C, compared with control conditions (NS), a major fraction
(.80%) of Cx32 degraded rapidly under androgen-depleted
conditions (STRIP) within 1 h, presumably by ERAD,
whereas the remaining fraction (,20%), most likely repre-
senting a fraction that escapes ERAD, degraded at a slower
rate, consistent with its normal trafficking and degradation.
Moreover, a significant fraction of Cx32 destined for ERAD
was rescued upon androgen replenishment (STRIP1MB).
Furthermore, lactacystin (STRIP1LAC) and ALLN (STRIP1
ALLN) also prevented degradation. We also consistently
observed that lactacystin and ALLN treatment caused the
emergence of two additional Cx32 forms that migrated
slower on SDS-PAGE and whose degradation was also pre-
vented by lactacystin and ALLN. These additional forms of
Cx32, most likely resulting from the post-translational mod-
ifications, remain to be further characterized. Taken to-
gether, these data document that androgen depletion trig-
gers degradation of a major fraction of Cx32 from the ER by
ERAD in a proteasomal inhibitor-sensitive manner.
Androgens and Degradation of Cx43
To investigate if androgens also regulate the degradation of
other members of the Cx gene family, androgen-responsive
early passage LNCaP cells were infected with the recombi-
nant retrovirus containing Cx43. Connexin43 has a low se-
quence similarity to Cx32 (Kumar and Gilula, 1996). After
isolating several independent clones and characterizing
them for the expression, we studied the degradation of Cx43
in one well-characterized clone in the presence and absence
of androgens. As shown in Figure 10, androgen depletion
degraded Cx43, which was prevented by replenishment of
MB and MG132 and leupeptin; moreover, the combined
effect was additive. These findings suggest that Cx43 also
degrades upon androgen depletion, most likely, by a mech-
anism similar to that involved in the degradation of Cx32
despite sequence dissimilarity.
Figure 8. Androgen depletion triggers Cx32 degradation en route to Golgi. (A) Cx32-expressing LNCaP cells, seeded on glass coverslips and
grown at 37°C for 3 d, were switched to charcoal-stripped serum for 24 h at 37°C to deplete the pre-existing pool of Cx32. Control cells were
maintained in normal serum (NS, a and b), and charcoal-stripped cells were further grown for 24 h in charcoal-stripped serum (STRIP, c and
d) and in charcoal-stripped serum supplemented with MB (STRIP1 MB, e and f). Monensin (10 mM) was used to block intra-Golgi transport
for the last 8 h (1MONENSIN) and the vehicle treated cells were used as control (2MONENSIN). Note that Cx32 (green) does not accumulate
in the intra-Golgi compartment under androgen-depleted conditions upon monensin treatment, whereas E-cadherin (red) accumulates (see
d). Note also that substantial intra-Golgi accumulation of both Cx32 and E-cadherin is observed in the presence of monensin in control or
MB-treated cells (b and f). (B) Cx32-expressing LNCaP cells, seeded on glass coverslips and grown at 37°C for 3 d, were maintained in normal
serum (a) or were switched to charcoal-stripped serum for 24 h at 37°C to deplete the pre-existing pool of Cx32. Control and charcoal-stripped
cells were then further grown at 37°C (a and b) or at 15°C (c–f) for an additional 24 h in normal serum (c and e) or in charcoal-stripped serum
(b, d, and f) in the absence (c and d) and presence of MG132 (e and f). Subcellular localization of Cx32 was studied by immunocytochemical
analysis. Note also that at 15°C, no intracellular immunostaining of Cx32 is observed in charcoal-stripped serum (d). The degradation is
prevented by MG132 (f).
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Cx32 Carboxyl Terminal Tail Does Not Mediate
Degradation
Despite a large body of evidence that Cxs degrade via the
lysosomal and proteasomal pathways (Laing and Beyer,
2000; VanSlyke et al., 2001; Segretain and Falk, 2004; Laird,
2005), it is as yet unknown which motifs control sorting of
Cxs to lysosomes or proteasomes. Because both Cx32 and
Cx43 were degraded similarly upon androgen depletion and
because carboxyl termini of most members of the Cx gene
family are highly divergent, we reasoned that these termini
are unlikely to harbor sequence motifs that determine deg-
radation upon androgen depletion. Hence, we examined the
degradation pattern of a carboxy terminus–deleted mutant
of Cx32, designated as Cx32-T-220 (aa 221–283 deleted) upon
androgen depletion. This mutant lacks all the consensus
phosphorylation sites as well as 9 of 12 lysines that are likely
to be ubiquitinated (Laird, 2005).
Androgen-responsive early passage LNCaP cells were in-
fected with the recombinant retroviruses containing the
wild-type and carboxy terminus–deleted mutant, and sev-
eral independent clones were isolated and characterized for
the expression and degradation upon androgen depletion.
As shown in Figure 11, we found that the Cx32-T-220 mu-
tant, like its full-length counterpart, was also degraded upon
androgen depletion as assessed by immunocytochemical
(Figure 11B) and Western blot analyses (Figure 11A). Gap
junctions composed of this mutant, however, appeared to be
smaller compared with those formed by the full length Cx32.
These data suggest that the carboxy terminus of Cx32 is
dispensable for degradation and is unlikely to harbor motifs
that determine its degradation upon androgen depletion.
Collectively, the degradation of Cx43 and carboxy terminus
deleted Cx32 upon androgen depletion indicate that the
molecular determinants are likely to reside in the cytoplas-
mic loops or in domains that are conserved between Cxs.
Our ongoing studies are directed toward identifying do-
mains in Cxs that confer sensitivity toward degradation
upon androgen depletion.
DISCUSSION
In this study we show that androgens control the expression
level of Cx32—and hence the extent of gap junction forma-
tion—post-translationally in androgen-responsive human
prostate cancer cells in which the assembly of Cxs into gap
junctions is highly efficient. In the absence of androgens, a
major fraction of Cx32 is degraded from ER, presumably by
ERAD, whereas in their presence, this fraction is rescued
from degradation. Thus, androgens seem to regulate the
formation and degradation of gap junctions in a novel way:
by rerouting the pool of Cx32, which normally would have
been degraded from the early secretory compartment, to the
cell surface, and enhancing the cell surface–associated pool
amenable for gap junction assembly. Moreover, we also
Figure 9. Androgen-regulated ERAD of connexin32.
(A) Wild-type LNCaP cells were transfected transiently
with DsRed-Cx32 (DsRed-Cx32) and pEYFP-N1. After
12 h, cells were switched to normal serum (NS) and char-
coal-stripped serum (STRIP) containing MB (STRIP1
MB) or MG132 (STRIP1MG132). Degradation of DsRed-
Cx32 was assessed 24 h later by immunocytochemical
analysis. Note degradation of ER-trapped DsRed-Cx32
upon androgen depletion (compare column 1 with col-
umn 2). Note also that the degradation is prevented by
MB (column 3) or MG132 (column 4). (B) Metabolic
turnover of Cx32 was analyzed in normal serum and in
charcoal-stripped serum containing MB, lactacystin (10
mM), and ALLN (100 mM) as described in Materials and
Methods. Between 1–5 3 106 TCA-insoluble counts were
immunoprecipitated at indicated time points (0–4 h).
Note that compared with normal serum (NS, lanes 1–2)
a major fraction (.80%) is degraded within 1 h of chase
in charcoal-stripped serum (STRIP, lanes 1 and 2). Re-
plenishment of androgens (STRIP1MB, lanes 1–4) de-
creases the rate of degradation. Also Cx32 levels are not
significantly altered in charcoal-stripped serum contain-
ing either lactacystin (STRIP1LACTA, lanes 1–4) or
ALLN (STRIP1ALLN, lanes 1–4). Note also that two
slower migrating forms of Cx32 detected in lactacystin-
and ALLN-treated cells most likely represent post-
translational modifications that result before inhibition
of proteasomal function or immediately thereafter. (C)
Plot of the time course of pulse-labeled Cx32 turnover
during the 4-h chase period. The plot was drawn from
the data obtained from the densitometric analyses of the
typical pulse-chased blots using AlphaDigiDoc 1201
software. Each experiment was repeated twice with
qualitatively similar results. Note that Cx32 has a sig-
nificantly shorter half-life in androgen-depleted, char-
coal-stripped serum, and degradation is prevented by
proteasomal inhibition. l, NS; Œ, STRIP1MB; f,
STRIP; e, STRIP1LACTA; ‚, STRIP1ALLN.
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show that Cx32 and Cx43 degrade by a similar mechanism
and that degradation does not involve the entire cytoplasmic
tail of Cx32. The significance of these data are further un-
derscored by the lack of appreciable effect of androgens on
the degradation of adherens junction–associated proteins,
E-cadherin and a- and b-catenins, and tight junction–asso-
ciated protein, occludin. Thus, in this model system, andro-
gen-regulated proteasome—and not the lysosome—medi-
ated degradation of Cx32 appeared to be the major control
point in modulating the formation and degradation of gap
junctions.
The present study was prompted by three independent
lines of inquiry. First, previous findings had shown that
Cx32 was expressed by the well-differentiated cells of the
liver (Dermietzel et al., 1987; Stutenkemper et al., 1992;
Kojima et al., 1996, 2001) and cells derived from other hor-
mone-responsive tissues, such as pancreas and thyroid,
where gap junctional communication had been documented
to play an important role in regulating differentiation (Munari-
Sliem et al., 1991; Munari-Sliem and Rousset, 1996; Meda,
1996; Guerrier et al., 1995; Stock et al., 1998). Second, we had
previously shown that Cx32 was expressed by the well-
differentiated epithelial cells of the prostate and prostate
tumors and that its expression coincided with the morpho-
logical, histological and cellular (secretory) differentiation of
the prostate (Mehta et al., 1999; Habermann et al., 2001, 2002).
Third, consistent with the tumor suppressing and prodiffer-
entiating role of Cx32 in vivo and in vitro (Mehta et al., 1999;
King and Lampe, 2004, 2005; King et al., 2005), and on the
basis of the prodifferentiating role of androgens in prostate
morphogenesis (Cunha et al., 1992), we reasoned that andro-
gens might regulate its assembly into gap junctions.
Multiple lines of evidence suggested that in the absence of
androgens a major proportion of Cx32 was degraded from
the ER en route to the Golgi in a proteasomal inhibitor-
sensitive manner. First, in the absence of androgens, Cx32
was barely detectable by immunocytochemical analysis at
37°C, or at 15°C, when its transport from ER to Golgi was
blocked (Figure 8B). Second, inhibition of proteasomal func-
tion at 15°C under androgen-depleted conditions enhanced
expression level of Cx32 and caused its intracellular accu-
mulation (Figure 8B). Third, ER exit of Cx32 and its subse-
quent accumulation in the cis-Golgi upon monensin block
was observed only when cells were grown in androgen-
containing medium (Figure 8A). Fourth, a DsRed-Cx32 chi-
mera that remained trapped in the ER was also degraded
upon androgen depletion and its degradation was pre-
vented by MG132 (Figure 9A). Fifth, pulse chase analysis of
metabolically labeled Cx32 indicated that it degraded rap-
idly soon after its synthesis in cells grown in charcoal-
stripped (androgen-depleted) serum in stark contrast to cells
grown in normal serum and in charcoal-stripped serum
supplemented with the androgen or lactacystin or ALLN.
Finally, inhibiting lysosomal function under androgen-de-
pleted conditions prevented the degradation of only cell
surface and gap junction-associated pool of Cx32 (Figure 7).
These results suggest that in the absence of androgens, Cx32
is degraded soon after its synthesis and that only the newly
synthesized intracellular pool of Cx32 appears to be affected
by the androgens or MG132 under androgen-depleted con-
ditions. The gap junctional plaque associated pool seems to
be predominantly degraded in the lysosome both in the
presence and absence of androgens. On inhibition of protea-
somal function, intracellularly accumulated Cx32 appeared
to localize in discrete puncta or aggregates of variable sizes
that were found to be scattered through out the cytoplasm.
These puncta did not seem to reside in the ER, Golgi, and
trans-Golgi network, as assessed by colocalization studies
using well-established markers for these organelles and
seemed to reside in as yet undefined compartment as as-
sessed by the cell fractionation assay (Figure 7C). Further
studies are required to identify the biochemical nature of
these aggregates and the subcellular compartments in which
they reside.
As assessed by quantitative real-time PCR analysis, an-
drogens neither induced the transcription of endogenous
Cx32 gene (data not shown) nor affected Cx32 mRNA level
driven by the retroviral promoter (Figure 6D). Moreover, it
also seemed unlikely that androgens regulated the expres-
sion of Cx32 at the translational level, because inhibition of
proteasomal function under androgen-depleted conditions
increased steady state expression level and caused substan-
tial intracellular accumulation (Figure 6A). These data indi-
cate that in the absence of androgens, Cx32 protein was
synthesized but was degraded immediately after its synthe-
sis. Furthermore, the fact that Cx32 accumulated intracellu-
larly to a similar extent upon inhibition of proteasomal
function both in the presence and absence of androgens at
15°C, when ER-to-Golgi transport was blocked (Bannykh et
al., 1996; Hauri et al., 2000), argue further against transla-
tional control as one of the mechanisms for decreasing the
expression level (Figure 8B). Thus, the level of Cx32 seemed
Figure 10. Degradation of Cx43 upon an-
drogen depletion. Cx43-expressing LNCaP
cells were seeded in six-well clusters and al-
lowed to grow to confluence as described in
Figure 6. Cells were then further grown for
24 h in normal serum (CONTROL, top left),
in charcoal-stripped serum (STRIP, top mid-
dle), or in charcoal-stripped serum contain-
ing MB (STRIP1MB, 5 nM, top right), MG132
(20 mM; STRIP1MG132, bottom left), leu-
peptin (50 mM; STRIP1LEUP, bottom
middle), and MG132 and leupeptin
(STRIP1MG1321LEUP, bottom right). Ex-
pression levels of Cx43 and gap junctions
were analyzed by immunocytochemical anal-
ysis as described in Materials and Methods.
Note that Cx43 and gap junctions are de-
graded in charcoal-stripped serum, and there
is no intracellular accumulation. Note also
that MB prevents the degradation of Cx43 and facilitates gap junction formation. Also, degradation is prevented by MG132 and leupeptin,
and combined treatment results in a higher intracellular level.
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to be controlled by the androgens post-translationally. Be-
cause Cx43 was also degraded upon androgen depletion, it
appears that this may be a common mechanism by which
expression level of some Cxs is regulated to permit gap
junction assembly. In previous findings a decrease in, or loss
of, Cx32 expression was observed upon partial hepatectomy
and in primary cultures of rat hepatocytes, without signifi-
cant changes in the mRNA level, but no rational explanation
was put forward (Dermietzel et al., 1987; Kren et al., 1993;
Kojima et al., 1996). It is possible that in those studies the
expression level of Cx32 was regulated post-translationally
by a similar mechanism involving degradation.
Our findings suggest that AR-mediated signaling was
required for maintaining Cx32 expression level and prevent-
ing its degradation post-translationally. In AR-negative DU-
145 cells, in which Cx32 was introduced using recombinant
retrovirus, depletion of androgens neither enhanced its
expression level nor induced degradation. Moreover, in
androgen-responsive LNCaP cells, Cx32 degraded rapidly
in androgen-containing medium upon addition of an anti-
androgen, bicalutamide, which inhibits AR-mediated signal-
ing by competing with the androgens (Iversen, 2002). These
findings document that the depletion of androgens is the
predominant factor responsible for the degradation of Cx32
when cells are grown in charcoal-stripped serum—and not
other factors that might also be removed upon charcoal
stripping. When AR was overexpressed in Cx32-expressing
LNCaP cells, the expression level of Cx32 was increased,
along with the size of the gap junctions, most likely due to
increased level of AR which was available for the hormones
to bind. These results also corroborate the androgen dose–
response data and concur with the notion that androgens
themselves increase AR level by stabilizing it (Dehm and
Tindall, 2005; Shen and Coetzee, 2005).
One salient feature of our data is that androgen depletion
induced degradation of only Cx32 and had no effect on the
degradation of adherens junction–associated proteins E-cad-
herin and a- and b-catenins and tight junction–associated
protein, occludin (Figure 5). Because cadherins had previ-
ously been shown to facilitate the trafficking and assembly of
Cxs into gap junctions (Musil et al., 1990; Jongen et al., 1991;
Hernandez-Blazquez et al., 2001), these data imply that the
degradation of Cx32 and gap junctions composed of it was
not triggered indirectly by the loss of E-cadherin or disas-
sembly of adherens junctions upon removal of androgens. It
is worth noticing that although the total level of occludin did
not decrease, androgen depletion decreased its detergent-
insoluble fraction, with a concomitant increase in the soluble
fraction, causing it to accumulate intracellularly. One possi-
ble interpretation of these data are that the trafficking of
occludin to the cell surface and its detergent insolubility
(that is, incorporation into tight junctions) might be regu-
lated by Cx32. This line of thought is well supported by
earlier studies, which showed that in cell lines derived from
Cx32 knock out mice, occludin remained in the cytoplasm
and reintroduction of Cx32 induced its trafficking and as-
sembly into tight junctions (Kojima et al., 2001, 2002). Thus,
it is possible that an increase in the detergent solubility of
occludin is indirectly affected by the degradation of Cx32
and gap junctions upon androgen removal. Further studies
are required to substantiate this notion.
Although Cx32 and Cx43 have previously been shown to
be degraded by the proteasomal and the lysosomal path-
ways in several cell culture model systems (Laing and Beyer,
1995, 2000; Laing et al., 1997; Musil et al., 2000; VanSlyke and
Musil, 2002; Laird, 2005; VanSlyke and Musil, 2005), the
physiological stimuli that trigger their degradation or dic-
tate the choice of the pathway have not yet been explored.
Using cell lines that differed widely in their ability to assem-
ble Cx43 and Cx32 into functional gap junctions, a substan-
tial portion of newly synthesized Cx43 and Cx32 was shown
to be degraded by ERAD; moreover, the degradation was
prevented by nontoxic hyperthermic and oxidative stress or
by proteasomal inhibitors and was accompanied by en-
hanced gap junction assembly and function (Musil et al.,
2000; VanSlyke and Musil, 2005). Furthermore, similar treat-
ments also increased gap junctions by preventing the deg-
radation of the cell surface–associated pool of Cx43 and by
enhancing its recycling (VanSlyke and Musil, 2005). Thus, it
has been proposed that regulation of Cx turnover might be
an important mechanism to enhance gap junction assembly
and function upon physiological demand (Musil et al., 2000;
VanSlyke and Musil, 2005). Our findings—that androgens
enhanced the expression level of Cx32 by rerouting its pre-
sumably ERAD-targeted pool to the cell surface—lend cre-
dence to the above notion, and for the first time have iden-
tified a novel, hormonally regulated route by which the
formation and degradation of gap junctions could be rapidly
controlled in response to physiological stimuli from the ER.
Although ERAD has been shown to be a common mecha-
nism by which misfolded proteins are degraded, the molec-
ular mechanisms have not yet been elucidated (Arvan et al.,
2002; Ellgaard and Helenius, 2003; McCracken and Brodsky,
Figure 11. The carboxy terminus of Cx32 is not involved in the
degradation upon androgen depletion. (A and B) LNCaP cells ex-
pressing full length Cx32 (Cx32-WT) and the carboxy terminus
deleted mutant (Cx32-T-220) were switched to charcoal-stripped
serum for 24–48 h, and degradation of gap junctions was analyzed
by immunocytochemical (B, 24 h) and Western blot (A) analyses.
Note that, upon androgen depletion, wild-type and mutant Cx32, as
well as gap junctions composed of them, are degraded. Note also
that gap junctions composed of mutant Cx32 are smaller.
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2003; Meusser et al., 2005). Hence, the mechanism by which
androgens reroute the ERAD-targeted pool of Cx32 to the
cell surface is likely to be complex and may be related to
induction and repression of factors that regulate Cx traffick-
ing and degradation or both. Based on our findings, it is
tempting to speculate that degradation of Cxs before their
assembly into gap junctions by ERAD itself is a physiolog-
ically regulated event.
Requirement for androgens throughout normal prostatic
development and prostate cancer progression is well estab-
lished (Cunha et al., 1987, 1992). Androgen-responsive LNCaP
cells have been widely used for studying the progression of
human prostate cancer from an androgen-dependent state to
an androgen-independent state in vitro (Webber et al., 1996).
Although the molecular events involved during the pro-
gression of prostate cancer from an indolent, hormone
(androgen)-dependent state to an invasive, androgen-inde-
pendent state are not fully understood, the progression is
characterized by the emergence of cells that no longer de-
pend on androgens for survival (Abate-Shen and Shen, 2000;
Feldman and Feldman, 2001). Because rescue of Cx32 and
Cx43 degradation upon addition of androgens was accom-
panied by parallel changes in gap junction function, our
findings suggest that it is likely to be intimately involved in
regulating the physiological functions of the prostate. More-
over, the findings that in a cell culture model that mimics the
progression of human prostate cancer (Igawa et al., 2002),
degradation of Cxs as well as formation of gap junctions—
and not of other junction-associated proteins—is androgen-
dependent strongly implicate an important role of junctional
communication in the prostate morphogenesis and onco-
genesis.
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